血液肿瘤疾病专栏

儿童异基因造血干细胞移植术后巨细胞病毒感染临床分析

  • ZHU Chenglin ,
  • CHEN Guanghua ,
  • ZHAI Zong ,
  • et al
展开
  • 1.苏州大学附属儿童医院血液肿瘤科(江苏苏州 215000); 2.苏州大学附属第一医院 江苏省血液研究所(江苏苏州 215000)

网络出版日期: 2020-09-17

基金资助

苏州市科技计划项目(No.SS2019065);江苏省妇幼健康科研项目(No.F201815);国家自然科学基金项 目( No.81300444);江苏省自然科学基金项目(No.BK20130273);苏州市“科教兴卫”青年科技项目(No. KJXW2019024)

Clinical analysis of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation in children

  • 朱成琳,陈广华,翟 宗,等
Expand
  • 1.Department of Hematology and Oncology, Children’s Hospital Affiliated to Soochow University, Suzhou 215000, Jiangsu, China; 2. Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215000, Jiangsu, China

Online published: 2020-09-17

摘要

目的 探讨儿童异基因造血干细胞移植(allo-HSCT)后巨细胞病毒(CMV)感染的危险因素及临床相关特征。 方法 收集2016年1月至2018年12月共269例allo-HSCT患儿的临床资料。监测移植后全血CMV-DNA拷贝数,分析 移植患儿CMV感染发生率、发生时间、危险因素及预后。结果 269例患儿中,男167例、女102例,中位年龄65个月 (33~115个月),其中165例发生CMV感染,感染率为61.3%,感染发生时间为移植后23 d(15~34 d),感染持续时间 38 d(25~66 d)。Logistic回归分析发现患儿移植年龄>65个月、移植后发生Ⅱ~Ⅳ级aGVHD是发生CMV感染的危险因 素,而亲缘全相合移植能降低CMV感染发生风险(P<0.05)。 发生Ⅱ~Ⅳ级急性移植物抗宿主病(aGVHD)及使用脐血移 植与发生难治性CMV感染相关(P<0.05)。 难治性CMV感染组与非难治性CMV感染组总体生存率及无病生存率的差异 有统计学意义(P<0.05)。 结论 移植患儿年龄大、Ⅱ~Ⅳ级aGVHD能增加CMV感染的发生风险,亲缘全相合移植能降低 CMV感染的发生风险。脐血移植后易发生难治性CMV感染;难治性CMV感染初次检测到CMV感染时间早,峰值高。

本文引用格式

ZHU Chenglin , CHEN Guanghua , ZHAI Zong , et al . 儿童异基因造血干细胞移植术后巨细胞病毒感染临床分析[J]. 临床儿科杂志, 2020 , 38(9) : 641 . DOI: 10.3969/j.issn.1000-3606.2020.09.001

Abstract

Objective To explore the risk factors and clinical characteristics of cytomegalovirus (CMV) infection after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in children. Methods The clinical data of allo-HSCT in 269 children from January 2016 to December 2018 were collected. The copies of CMV-DNA in whole blood after transplantation were monitored. The incidence, time, risk factors, and prognosis of CMV infection were analyzed. Results A total of 269 cases (167 males and 102 females) were included and median age was months (33 - 115 months). Among them, 165 cases had CMV infection and the infection rate was 61.3%. The infection occurred 23 days (15 - 34 days) after transplantation, and the infection lasted 38 days (25 - 66 days). Multivariate logistic regression analysis showed that transplantation age > 65 months and grade Ⅱ-Ⅳ aGVHD after transplantation were risk factors for CMV infection, while sibling donor hematopoietic stem cell transplantation (Sib-HSCT) could reduce the incidence of CMV infection (P < 0.05). The occurrence of grade Ⅱ-Ⅳ aGVHD and the use of cord blood transplantation are associated with the incidence of refractory CMV infection (P < 0.05). The difference of the overall survival rate and disease-free survival rate between the refractory CMV infection group and the non-refractory CMV infection group was statistically significant (P < 0.05). Conclusion The risk of CMV infection can be increased by older children and Ⅱ-Ⅳ aGVHD, while the risk can be reduced by Sib-HSCT. Refractory CMV infection was likely to occur after umbilical cord blood transplantation, and the initial detection time of refractory CMV infection was early and the peak value was high.
文章导航

/